HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Watson Private Label Nicotine Gum Launching In September

This article was originally published in The Tan Sheet

Executive Summary

Watson Pharmaceuticals will introduce its private label nicotine polacrilex gum "before the end of the third quarter," the company announced during a conference call with securities analysts Aug. 5. Retail chains that have agreed to carry the product include CVS, Walgreen, Rite-Aid, Eckerd, American Stores and Wal-Mart.

You may also be interested in...

Novartis Reaches Deal With Watson For Nicotine Replacement Products

Watson Pharmaceuticals is expanding the over-the-counter sales base for its smoking cessation line through a partnership with Novartis Consumer Health

Generic nicotine gum

Watson Pharmaceuticals subsidiary Rugby Labs adds private label nicotine polacrilex gum in 2 mg, 4 mg doses to its OTC lineup, firm announces. Gum will roll out to independent drugstores, government and military accounts "within the next few weeks," Watson says. Generic firm decided to expand gum's distribution through Rugby due to increased manufacturing capacity. Company's smoking cessation gum, equivalent to GlaxoSmithKline's Nicorette, initially launched in 1999 to retail accounts including CVS, Walgreen's (1"The Tan Sheet" Aug. 16, 1999, p. 3)...

SmithKline Seeks Injunction Against Watson Nicotine Gum Labeling

SmithKline Beecham Consumer Healthcare alleges copyright infringement of the company's Nicorette smoking cessation gum in a lawsuit filed against Watson Pharmaceuticals and its subsidiaries, Watson Laboratories and Circa Pharmaceuticals, Aug. 26.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts